Evidence map›Paper›PMID 29236685›Full record

ArticleNature2017

Origin and differentiation of human memory CD8 T cells after vaccination.

Rama S Akondy, Mark Fitch, Srilatha Edupuganti, Shu Yang, Haydn T Kissick, Kelvin W Li, Ben A Youngblood, Hossam A Abdelsamed, Donald J McGuire, Kristen W Cohen and 14 more

Abstract read
In one paragraph

Article in Nature, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 332 papers.

0numbers the graph read from it
0cells of the map it votes in
332citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

332 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Innate-like Gene Expression of Lung-Resident Memory CD8American journal of respiratory and critical care medicine · 2021
    Trial
  4. Trial
  5. Article
  6. T Cell Thoughts.Immunological reviews · 2026
    Review
  7. Review
  8. CD8Cell reports. Medicine · 2026
    Review
  9. GRP75 sustains CD8Cell death and differentiation · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. CD8Science China. Life sciences · 2026
    Review
  17. Review
  18. Review
  19. Article
  20. Nonoxidative pentose phosphate pathway regulates CD8Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article

272 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Rama S AkondyEmory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA.
Mark FitchDepartment of Nutritional Sciences and Toxicology, UC Berkeley, Berkeley, California, USA.
Srilatha EdupugantiDepartment of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.
Shu YangEmory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA.
Haydn T KissickDepartment of Urology, Emory University School of Medicine, Atlanta, Georgia, USA.
Kelvin W LiKineMed Inc., Emeryville California, USA.
Ben A YoungbloodEmory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA.
Hossam A AbdelsamedSt.Jude Children's Research Hospital, Memphis, Tennessee, USA.
Donald J McGuireEmory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA.
Kristen W CohenVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Gabriela AlexeDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
Shashi NagarDepartment of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.
Megan M McCauslandEmory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA.
Satish GuptaStrand Lifesciences, Bangalore, India.
Pramila TataStrand Lifesciences, Bangalore, India.
W Nicholas HainingDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
M Juliana McElrathVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
David ZhangDepartment of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, California, USA.
Bin HuDepartment of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, California, USA.
William J GreenleafDepartment of Genetics, Stanford University School of Medicine, Stanford, California, USA.
Jorg J GoronzyDepartment of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, California, USA.
Mark J MulliganEmory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA.
Marc HellersteinDepartment of Nutritional Sciences and Toxicology, UC Berkeley, Berkeley, California, USA.
Rafi AhmedEmory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA.

Funding

LC: HIV Vaccine Trials NetworkUM1AI068618 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Margaret Juliana McElrath · 2011 to 2026
$483.6M
VACCINE INDUCED IMMUNITY IN THE YOUNG AND AGEDU19AI057266 · NIAID · EMORY UNIVERSITY · PI Rafi Ahmed · 2003 to 2026
$81.7M
Seattle Vaccine Trials UnitUM1AI069481 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Rachel Ann Bender Ignacio, Margaret Juliana McElrath · 2012 to 2026
$24.4M
Training Program in Adult and Pediatric RheumatologyT32AR050942 · NIAMS · STANFORD UNIVERSITY · PI LEWIS, DAVID BRAM, ROBINSON, WILLIAM H · 2005 to 2025
$6.6M
Memory T Cell Development and Survival in T Cell Responses of Older IndividualsR01AI129191 · NIAID · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI GORONZY, JORG J · 2017 to 2021
$1.9M
T CELL KINETICS AND SOURCES--EFFECTS OF HIV AND THERAPYR01AI043866 · NIAID · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI HELLERSTEIN, MARC KOPEL · 1999 to 2002
$849k
NIAID NIH HHS R01 AI043866NIAID NIH HHS R01 AI129191NIAID NIH HHS U19 AI057266NIAID NIH HHS UM1 AI068618NIAID NIH HHS UM1 AI069481NIAMS NIH HHS T32 AR050942NIH HHS R01-AI43866-07
6 · The paper itself

Abstract

The differentiation of human memory CD8 T cells is not well understood. Here we address this issue using the live yellow fever virus (YFV) vaccine, which induces long-term immunity in humans. We used in vivo deuterium labelling to mark CD8 T cells that proliferated in response to the virus and then assessed cellular turnover and longevity by quantifying deuterium dilution kinetics in YFV-specific CD8 T cells using mass spectrometry. This longitudinal analysis showed that the memory pool originates from CD8 T cells that divided extensively during the first two weeks after infection and is maintained by quiescent cells that divide less than once every year (doubling time of over 450 days). Although these long-lived YFV-specific memory CD8 T cells did not express effector molecules, their epigenetic landscape resembled that of effector CD8 T cells. This open chromatin profile at effector genes was maintained in memory CD8 T cells isolated even a decade after vaccination, indicating that these cells retain an epigenetic fingerprint of their effector history and remain poised to respond rapidly upon re-exposure to the pathogen.

Indexed as

Epigenesis, GeneticAnimalsCD8-Positive T-LymphocytesCell DifferentiationCell ProliferationChromatinDeuteriumDNA MethylationGene Expression ProfilingHalf-LifeHumansImmunologic MemoryLymphocyte CountMiceRadioisotope Dilution TechniqueTranscription, GeneticChromatinDeuteriumYellow Fever Vaccine

Identifiers

PMID29236685
PMCPMC6037316

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.